74
Views
4
CrossRef citations to date
0
Altmetric
Case reports

Transient and reversible thrombocytopenia in a psoriatic patient treated with etanercept

, , , &
Pages 117-118 | Published online: 08 Feb 2010

References

  • Gudjonsson JE, Elder JT. Psoriasis: Epidemiology. Clin Dermatol. 2007; 25:535–546.
  • Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD. Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions. Clin Exp Immunol. 1994; 96:146–151.
  • Pietrzak AT, Zalewska A, Chodorowska G, Krasowska D, Michalak-stoma A, Nockowski P, Cytokines and anticytokines in psoriasis. Clin Chim Acta. 2008; 394:7–21.
  • Pathare SK, Heycock C, Hamilton J. TNFalpha blocker- induced thrombocytopenia. Rheumatology (Oxford). 2006; 45:1313–1314.
  • Kuruvilla J, Leitch HA, Vickars LM, Galbraith PF, Li CH, Al-saab S, Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor. Eur J Haematol. 2003; 71:396–398.
  • Vidal F, Fontova R, Richart C. Severe neutropenia and thrombocytopenia associated with infliximab. Ann Intern Med. 2003; 139:W–W63.
  • Stinco G, Piccirillo F, Patrone P. Transient and slight thrombocytopaenia induced by etanercept during treatment of psoriatic arthritis. Acta Derm Venereol. 2008; 88:281–282.
  • Lahbabi I, Adamski H, Le Jean S, Cannieux V, Polard E, Chevrant-Breton J. Neutropenia and thrombocytopenia in a patient presenting psoriasis treated with etanercept. Ann Dermatol Venereol. 2008; 135:409–410.
  • Phelan C, Wooltorton E. Infliximab and serious hematologic events. CMAJ. 2004; 171:1045.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.